What is Zacks Small Cap’s Estimate for MGRM Q1 Earnings?

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Equities research analysts at Zacks Small Cap issued their Q1 2025 earnings per share estimates for Monogram Orthopaedics in a research note issued to investors on Thursday, March 13th. Zacks Small Cap analyst T. Kerr anticipates that the company will earn ($0.10) per share for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Zacks Small Cap also issued estimates for Monogram Orthopaedics’ Q2 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.44) EPS and FY2026 earnings at ($0.16) EPS.

Several other analysts have also issued reports on the company. Roth Mkm increased their price objective on Monogram Orthopaedics from $4.00 to $5.40 and gave the stock a “buy” rating in a report on Tuesday. Roth Capital set a $5.40 target price on Monogram Orthopaedics in a report on Tuesday.

Monogram Orthopaedics Trading Down 6.5 %

Shares of NASDAQ:MGRM opened at $3.43 on Monday. Monogram Orthopaedics has a 1 year low of $1.53 and a 1 year high of $4.90. The business has a fifty day simple moving average of $2.58 and a 200 day simple moving average of $2.50. The firm has a market cap of $121.04 million, a price-to-earnings ratio of -7.30 and a beta of 1.66.

Monogram Orthopaedics (NASDAQ:MGRM) last announced its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.03.

Hedge Funds Weigh In On Monogram Orthopaedics

Institutional investors have recently made changes to their positions in the business. Barclays PLC acquired a new stake in Monogram Orthopaedics during the third quarter worth about $29,000. State Street Corp acquired a new stake in Monogram Orthopaedics during the third quarter worth about $62,000. Geode Capital Management LLC grew its position in Monogram Orthopaedics by 1,267.4% during the third quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock worth $557,000 after buying an additional 194,776 shares in the last quarter. Jane Street Group LLC acquired a new stake in Monogram Orthopaedics during the fourth quarter worth about $25,000. Finally, Northern Trust Corp grew its position in Monogram Orthopaedics by 110.6% during the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after buying an additional 24,088 shares in the last quarter. 0.45% of the stock is currently owned by institutional investors.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.